Mindler, Sweden’s largest digital service for mental health, has raised 85 MSEK to meet the increasing demand of psychology services and accelerate its international growth. Schibsted is one of the investors in the latest round.
The three founders noted that too few Swedes sought treatment for mental health issues, and those who did tended to do it too late. In 2018, they founded Mindler to tackle this challenge by providing all Swedes with the opportunity to see a psychologist online. With 250 employees across Sweden and the Netherlands already, the digital platform is now looking for its next European market.
“Mental health is one of the major societal issues of our time, and unfortunately, many signs point towards an ever-greater need for psychology services in the future. Meanwhile, access to psychologists remains highly limited outside metropolitan areas. By bringing psychologists to patients, we are pleased to bridge this widening gap between supply and demand, providing more equal access to high-quality mental health care, regardless of where you live,” says Rickard Lagerqvist, CEO and Founder of Mindler.
The funds will be used to accelerate Mindler’s European expansion and to reinforce the startup’s organizational growth and platform development.
“We believe Mindler has what it takes to fundamentally impact patients’ mental health for the better. With a fully digitised patient journey, Mindler has the potential to increase quality, effectiveness and access to mental healthcare for patients. With Mindler, hopefully, even more people will not only get the help they need but also better care,” says Kajsa Gatenbeck, Investment Manager at Schibsted Growth
Mindler is a digital health app, allowing users to consult with a psychologist within 24 hours, via their smartphone. Mindler was founded in 2018 with the vision to give everyone the chance to see a psychologist, regardless of where you live or what your circumstances are. Headquartered in Stockholm, Mindler’s 200+ psychologists provide leading-edge psychological expertise and treatment to patients in Sweden and the Netherlands.